TickerFactsScreenerDevelopers

Edwards Lifesciences Corp (EW) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2008: $153.20M2009: $165.30M2010: $251.40M2015: $549.70M2016: $704.40M2017: $1.00B2018: $926.70M2019: $1.18B2020: $1.05B2021: $1.73B2022: $1.22B2023: $895.80M2024: $542.30M2025: $1.60B$1.60B
2008Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$1.60B+194.2%
2024$542.30M-39.5%
2023$895.80M-26.5%
2022$1.22B-29.7%
2021$1.73B+64.3%
2020$1.05B-10.9%
2019$1.18B+27.6%
2018$926.70M-7.4%
2017$1.00B+42.1%
2016$704.40M+28.1%
2015$549.70M—
2010$251.40M+52.1%
2009$165.30M+7.9%
2008$153.20M—